Related Experiment Videos

Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-kappaB in THP-1 macrophages

G Wang1, Y L Siow, K O

  • 1Department of Pharmacology and Institute of Cardiovascular Science and Medicine, Faculty of Medicine, University of Hong Kong, Hong Kong, China.

Insights

High homocysteine levels increase cardiovascular risk by boosting monocyte chemoattractant protein-1 (MCP-1) in macrophages. This occurs through activating the NF-kappaB pathway, promoting monocyte migration in atherosclerosis.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Molecular Biology

Background:

  • Homocysteine is a risk factor for cardiovascular disorders.
  • Monocyte recruitment is key in atherogenesis.
  • Monocyte chemoattractant protein-1 (MCP-1) drives monocyte migration into arterial walls.

Purpose of the Study:

  • To investigate homocysteine's effect on MCP-1 expression in macrophages.
  • To elucidate the mechanism behind homocysteine-induced MCP-1 expression.

Main Methods:

  • Human monocytic THP-1 cells differentiated into macrophages.
  • Incubation with varying concentrations of homocysteine (0.05-0.2 mM).
  • Nuclease protection assay and ELISA to quantify MCP-1 mRNA and protein levels.
  • Assessment of NF-kappaB pathway activation (IkappaB-alpha phosphorylation and mRNA expression).

Main Results:

  • Homocysteine significantly enhanced MCP-1 mRNA (up to 2.6-fold) and protein (up to 4.8-fold) expression.
  • Homocysteine-induced MCP-1 led to increased monocyte chemotaxis.
  • Activation of NF-kappaB was observed, indicated by increased IkappaB-alpha phosphorylation and reduced IkappaB-alpha mRNA.

Conclusions:

  • Pathological concentrations of homocysteine stimulate MCP-1 expression in macrophages.
  • This stimulation occurs via the activation of the NF-kappaB signaling pathway.
  • Findings highlight a mechanism linking homocysteine to atherogenesis through MCP-1 and NF-kappaB.

Related Concept Videos